Fertility Blood Test for Men: Beyond Semen Analysis

Why semen analysis remains the starting point

The World Health Organization’s 2021 lower reference limits are 1.4 mL semen volume, 16 million sperm/mL concentration, 42% total motility and 4% normal forms. These are fifth-centile reference limits from recent fertile fathers, not pass-or-fail conception thresholds; pregnancies occur above and below them. Our detailed sperm analysis result guide explains why one low value warrants a repeat rather than a diagnosis.

A semen sample varies more than many men expect. Fever, a 2-day versus 7-day abstinence interval, lubricants, incomplete collection and a long trip to the laboratory can each alter the result. In my clinical practice, a man with 3 million/mL after influenza has sometimes returned 10 to 12 weeks later with a result several-fold higher, because sperm development takes roughly 74 days plus epididymal transit.

A normal semen analysis does not rule out male contribution. It cannot reliably show sperm DNA damage, intermittent obstruction, endocrine symptoms, sexual dysfunction, genetic risk to offspring, or whether the sample represents the usual pattern. The AUA/ASRM guideline advises concurrent evaluation of both partners because fertility belongs to the couple, not to a single laboratory report (Schlegel et al., 2021).

What blood testing can and cannot answer

Blood testing can identify hormonal signalling, systemic illness and selected inherited causes; it cannot replace a repeat semen analysis performed in an experienced andrology laboratory. Think of the two tests as a production-line assessment: semen shows the finished product, while hormones and genes help locate a disruption upstream.

When male infertility hormone tests are most useful

The core initial panel is usually FSH and early-morning total testosterone. Add LH when testosterone is low, and add prolactin when sexual symptoms, low gonadotropins, headaches or visual symptoms raise concern for pituitary disease. A normal testosterone concentration does not prove normal sperm production, but a low result changes the interpretation of FSH and LH considerably.

Kantesti is an AI blood test analyzer that organizes hormone results alongside the laboratory’s own ranges, collection time and prior values. That context matters: total testosterone of 9.5 nmol/L at 4 pm is not equivalent to 9.5 nmol/L at 8 am after a normal night’s sleep. For practical timing issues, see our guide to morning hormone sampling.

I often see referrals prompted by a single “normal” testosterone result in a man with absent sperm. The more informative question is whether his FSH is appropriately responding to the low sperm output. Conversely, an elevated FSH does not say that treatment is impossible; it tells the reproductive urologist that the underlying problem is more likely testicular production than a blocked duct.

Symptoms that justify a broader endocrine review

Reduced morning erections, markedly reduced libido, loss of body hair, breast tenderness, anosmia, fatigue, headaches or peripheral-vision change are reasons to widen testing. A focused history of anabolic-androgenic steroid use, opioids, antipsychotics, chemotherapy, mumps orchitis and prior groin surgery is often more diagnostic than adding ten unselected biomarkers.

FSH and LH male fertility patterns doctors actually use

High FSH with azoospermia or severe oligozoospermia supports primary impairment of sperm production. An FSH of 18 IU/L is not a measure of how few sperm remain, and it cannot exclude focal sperm production that may be found by microdissection testicular sperm extraction. The reason is biological: damaged seminiferous tubules produce less inhibin B, so pituitary FSH rises in compensation.

Low or inappropriately normal FSH and LH with low testosterone suggests secondary hypogonadism, meaning inadequate hypothalamic or pituitary drive. This pattern may follow obesity, hyperprolactinaemia, severe illness, opioid exposure, anabolic steroid withdrawal or a pituitary disorder. The low FSH interpretation guide is useful, although no online result can determine the cause alone.

A frankly elevated LH with low testosterone also indicates primary testicular dysfunction, whereas high LH with normal testosterone can represent compensated dysfunction. I tell patients not to overread borderline values: sleep loss, acute illness and assay variation can move a result around the edge of a reference range. Repeating an unexpected result under comparable conditions is usually more sensible than reacting to a decimal point.

Testosterone, SHBG and estradiol: useful but easy to misread

Most UK and European laboratories quote adult male total testosterone roughly 8 to 30 nmol/L, while US reports often use about 300 to 1,000 ng/dL. Diagnostic thresholds differ: the Endocrine Society recommends symptoms plus consistently low morning testosterone, rather than a diagnosis from one sample (Bhasin et al., 2018). A result near 8 to 12 nmol/L deserves particular care because assay method and SHBG can change its meaning.

SHBG rises with ageing, hyperthyroidism, liver disease and some anticonvulsants; it can make total testosterone look reassuring while free testosterone is low. SHBG often falls with obesity, insulin resistance, hypothyroidism and androgen exposure, making total testosterone look low even when calculated free testosterone is adequate. Our explanation of SHBG and testosterone covers the calculation limits.

Estradiol is not a surrogate for sperm quality. It can help when obesity, gynecomastia, aromatase-inhibitor use or a testosterone-to-estradiol imbalance is clinically relevant, but standard immunoassays are less reliable at low male estradiol concentrations than sensitive LC-MS/MS methods. Dr. Thomas Klein’s practical rule is simple: treat the patient and pattern, not an isolated estradiol flag.

Why testosterone therapy can harm fertility

External testosterone suppresses pituitary LH and FSH through negative feedback, reducing intratesticular testosterone that sperm production needs. Men hoping to conceive should tell any prescriber before starting injections, gels or pellets; recovery after stopping can take months and is unpredictable, especially after long-term use.

When prolactin and thyroid blood tests add value

A prolactin value mildly above range is often transient. Exercise, sexual activity, stress, chest-wall irritation, poor sleep and medicines such as risperidone or metoclopramide may raise it; a calm morning repeat, sometimes with macroprolactin testing, prevents unnecessary imaging. Persistent elevation with low libido, erectile dysfunction, low testosterone, headache or visual symptoms needs clinical evaluation; see why prolactin needs repeating.

TSH with free T4 is reasonable when there are thyroid symptoms, abnormal SHBG, unexplained fatigue, weight change, tremor or abnormal semen volume. Overt hyperthyroidism can disrupt gonadotropin balance and increase SHBG, while severe hypothyroidism can impair libido and erectile function. A normal TSH makes clinically significant primary thyroid failure unlikely, but does not explain every fertility concern.

Kantesti is an AI blood test interpretation platform that identifies patterns such as low testosterone with low-normal LH and a raised prolactin, then frames them as clinician follow-up prompts rather than diagnoses. A pituitary MRI is considered after medical assessment, particularly for persistent marked prolactin elevation or neurological symptoms; the blood result alone does not choose imaging.

When symptoms are urgent

New severe headache, impaired peripheral vision, confusion, vomiting or rapidly worsening weakness merits urgent medical assessment, whether or not fertility is the original concern. A laboratory panel should never delay evaluation of neurological red flags.

Which genetic tests are indicated by severe sperm abnormalities

A karyotype counts and visually assesses chromosomes in cultured white cells. It can detect Klinefelter syndrome, usually 47,XXY, as well as balanced translocations that may matter for embryo chromosome testing. Karyotype does not detect every gene-level variant, so a normal result does not rule out genetic infertility.

The AUA/ASRM guideline recommends karyotype testing for azoospermia or sperm concentration below 5 million/mL when impaired production is suspected, especially with raised FSH or small testes (Schlegel et al., 2021). This threshold is pragmatic, not magical: family history, recurrent pregnancy loss and prior abnormal embryos can justify a genetics discussion at higher concentrations.

A chromosome result can carry emotional weight because it may have implications beyond fertility. I recommend a reproductive urologist or clinical geneticist explain what is inherited, what is not, and whether a partner test changes reproductive choices. For a useful companion discussion, our article on preconception blood testing helps couples coordinate their care.

Why a direct-to-consumer panel is not equivalent

Consumer ancestry genotyping usually examines a restricted set of common variants and cannot replace a clinical karyotype, validated Y-deletion assay or CFTR sequencing strategy. Laboratory method, variant classification and genetic counselling are part of the clinical test, not add-ons.

Y-chromosome microdeletions and CFTR testing

Y-chromosome testing looks for deletions in the AZF regions that contain genes involved in sperm production. Complete AZFa or AZFb deletions make successful sperm retrieval extraordinarily unlikely, whereas many men with AZFc deletions have sperm in ejaculate or can have sperm retrieved. If an AZFc deletion is passed through intracytoplasmic sperm injection, a male child will inherit it.

CFTR testing is considered for congenital bilateral absence of the vas deferens, obstructive azoospermia or persistently low semen volume, especially below the WHO lower limit of 1.4 mL. The partner may need CFTR carrier testing if a pathogenic variant is identified, because two disease-causing variants can cause cystic fibrosis in a child. Semen pH, fructose and examination help direct this decision.

Kantesti, an AI-powered blood test analysis tool, can make a genetic referral easier to understand by keeping hormone, semen and routine laboratory results in one chronological record. It cannot analyse a genetic sequence from a hormone panel, and no AI interpretation should replace pre- and post-test genetic counselling.

A low-volume sample is not always obstruction

Incomplete collection, short abstinence, retrograde ejaculation, androgen deficiency and some medicines can also reduce volume. A repeat sample with documented collection conditions is often the first step before assigning an obstruction label.

Routine blood tests that uncover systemic contributors

Diabetes, obesity, chronic kidney disease, liver disease and untreated sleep apnoea can lower testosterone or impair erectile function. An HbA1c of 6.5% or higher meets a diagnostic criterion for diabetes when confirmed appropriately, while 5.7% to 6.4% indicates increased diabetes risk. These thresholds matter because metabolic care improves overall health, although it does not guarantee a semen improvement.

Iron overload is an underappreciated endocrine clue. Ferritin persistently above 300 µg/L in men together with transferrin saturation above 45% can justify evaluation for iron overload, which may affect pituitary and gonadal function; ferritin alone rises with alcohol use, fatty liver and inflammation. Review the full iron-study pattern rather than treating a solitary ferritin number.

Zinc, selenium, vitamin D and folate testing should be driven by diet, malabsorption, bariatric surgery, restrictive eating or a documented deficiency—not by the hope that an expensive supplement stack will repair sperm. High-dose selenium can be harmful; doses above 400 micrograms/day exceed the adult tolerable upper intake level. Our evidence-based review of selenium dose safety explains the margin.

Medication review is a laboratory test of its own

Opioids, anabolic steroids, testosterone, finasteride, some antidepressants, chemotherapy and anti-seizure medicines may affect fertility through different mechanisms. Bring every prescription, injection, supplement and “test booster” to the appointment; stopping a medication without the prescriber can be unsafe.

How to prepare for a male fertility blood test

Avoid an intense workout, heavy alcohol intake and overnight shift work immediately before testing when possible. Acute illness can temporarily lower testosterone and change thyroid tests; if the result will guide fertility treatment, defer non-urgent sampling until recovery. Biotin supplements can interfere with some immunoassays, so report doses above 5 mg/day to the laboratory or clinician.

For semen testing, the WHO commonly advises 2 to 7 days of abstinence and reporting the exact interval. The same abstinence window should be used for a repeat whenever possible; comparing a 2-day sample with a 7-day sample can create a false trend. Our baseline blood test preparation guide has a practical checklist for mixed panels.

Do not stop prescribed medication merely to produce a “better” result. Instead, record medicines, supplements, fever, recent travel, sleep and collection time alongside the report. Kantesti can preserve this context next to future results, which is often more clinically useful than a colour-coded flag alone.

When to repeat an unexpected result

Repeat a low testosterone result on a separate morning before making a diagnosis unless severe symptoms demand urgent assessment. Semen analysis is commonly repeated after about 2 to 3 months when the first sample is abnormal, but the clinician may repeat sooner if collection quality was clearly compromised.

What if semen analysis is normal but pregnancy has not happened

Sperm DNA fragmentation testing may be discussed after recurrent pregnancy loss, repeated assisted-reproduction failure, clinical varicocele, smoking exposure, advanced paternal age or unexplained infertility. It is not yet a universal first-line test because assays and thresholds differ; a high result does not identify one unique treatment. That uncertainty is real, and couples deserve to hear it plainly.

Sexual timing is a surprisingly common missing detail. Intercourse every 1 to 2 days during the 6-day fertile window generally provides good sperm exposure without needing calendar perfection. Erectile dysfunction, pain, ejaculation difficulty and retrograde ejaculation deserve medical attention, not embarrassment; they can be more actionable than another micronutrient panel.

Dr. Thomas Klein has seen couples lose months chasing marginal morphology differences when the more decisive issue was intercourse avoidance after a prior low count. A reproductive urologist can integrate examination findings such as varicocele, epididymal fullness or absent vas deferens with the laboratory picture. Our guide to blood tests for low libido may help prepare for that conversation.

Do not turn a reference limit into a fertility verdict

WHO lower limits describe distributions in fertile men; they are not guaranteed pregnancy thresholds. A concentration of 17 million/mL is not automatically “fertile,” and 14 million/mL is not automatically infertile—the couple’s full clinical picture determines next steps.

How blood and genetic results can change treatment choices

Secondary hypogonadism may prompt treatment of obesity, hyperprolactinaemia, thyroid disease, medication effects or fertility-preserving hormonal therapy under specialist care. In selected men, clinicians use hCG with or without FSH to stimulate intratesticular testosterone and spermatogenesis; this is different from prescribing external testosterone. Response commonly takes months, not weeks.

High FSH and azoospermia often lead to counselling about micro-TESE, donor sperm or assisted reproduction rather than escalating supplements. The presence of a Y deletion or chromosome difference changes the expected retrieval rate and may change embryo-testing discussions. A genetic result is information, not an instruction to pursue one particular family-building route.

Obstructive patterns—normal-sized testes, normal FSH and low-volume azoospermia, for example—may lead to imaging, reconstruction discussion or surgical sperm retrieval. The male hormone panel guide is a helpful primer before a specialist visit, but treatment should be individualised.

Varicocele is an examination diagnosis as well as a laboratory question

A clinically palpable varicocele with abnormal semen parameters may be treatable in selected couples, but hormone results alone cannot establish it. Scrotal ultrasound can confirm anatomy when the specialist thinks it will alter management, not simply because a semen value is low.

Common mistakes with male fertility blood tests

Do not interpret total testosterone without collection time, SHBG, symptoms and repeat confirmation when it is low. Direct free-testosterone immunoassays are often less reliable than calculated free testosterone using total testosterone, SHBG and albumin, particularly near decision thresholds. A result flagged “low” on an app is a prompt for review, not a diagnosis.

Do not order broad genetic panels after one borderline motility result. Genetic testing has a higher diagnostic yield in azoospermia and severe oligozoospermia, while indiscriminate testing creates variants of uncertain significance that may cause anxiety without changing care. The same principle applies to sperm DNA fragmentation: use it where it may affect a decision.

Kantesti is an AI lab test interpretation service designed to point out result combinations and questions for a clinician, rather than sell certainty from incomplete data. We encourage users to check source documents carefully; our AI report accuracy checklist is especially useful when a PDF has been scanned or translated.

The supplement trap

Antioxidant combinations have mixed evidence and may not help every man. More is not safer: excessive zinc can cause copper deficiency, while high-dose folic acid can obscure vitamin B12 deficiency; test and treat documented problems with clinician guidance.

Results and symptoms that need faster specialist review

A semen result reporting zero sperm should be confirmed with centrifuged pellet examination before permanent conclusions are drawn. The clinician then separates obstruction from production failure using examination, FSH, testosterone, semen volume and sometimes genetics. Cryopreservation may be discussed if rare sperm are found, because a future sample may differ.

Headache with visual-field change, persistent nipple discharge, severe loss of libido and very low morning testosterone can indicate a pituitary problem requiring endocrine assessment. A prolactin result more than several times the upper reference limit raises concern more than a tiny isolated elevation, although laboratories and medicines still need review. Do not drive yourself to emergency care for an isolated borderline result without symptoms; call the clinician who ordered it.

A firm scrotal lump, sudden severe pain, fever with swelling or new breast enlargement requires in-person assessment rather than an online interpretation. Kantesti’s medical advisory board supports our clinician-led safety standards, but urgent physical findings need local medical services.

Where to seek care

A reproductive urologist or andrologist is often the best lead clinician for abnormal male results, working alongside a fertility specialist and endocrinologist when necessary. Ask for the original reports, semen collection details and a clear plan for repeat testing before the visit.

Using result trends without replacing fertility care

As of September 3, 2026, Kantesti is used by more than 2 million people across 127+ countries to interpret laboratory documents in multiple languages. Our system can organise FSH, LH, testosterone, prolactin, SHBG and routine markers across reports, but it does not inspect a semen specimen or make a fertility diagnosis.

A change from testosterone 11 to 9 nmol/L may be meaningless if one draw was at 8 am and the other after a night shift. A persistent fall across two or three comparable morning samples is more informative. Use our longitudinal lab trend guide to record conditions that give numbers their clinical meaning.

Privacy matters acutely with fertility and genetic results. Kantesti follows GDPR-aligned, privacy-focused data handling, but users should still remove unnecessary identifiers before sharing reports and decide deliberately who can access a family record. A secure interpretation is useful only if it improves the next clinical conversation.

Questions to bring to the appointment

Ask whether the semen pattern suggests impaired production, obstruction or a temporary factor; whether repeat testing is needed; and whether genetic counselling changes the plan. Also ask explicitly whether any current medication or supplement could suppress sperm production.

A practical sequence after an abnormal semen result

Step one is verification: repeat an abnormal semen analysis after a comparable 2-to-7-day abstinence interval, ideally in a specialist laboratory. Step two is targeted assessment—history, examination, FSH and morning testosterone for azoospermia, severe oligozoospermia or endocrine symptoms. Step three is genetics or imaging only when the pattern supports it.

Bring both partners’ timelines. Duration of trying, maternal age, prior pregnancies, miscarriages, IVF outcomes and intercourse frequency can change urgency and test selection more than a small shift in morphology. For an organised clinician discussion, use our blood test summary checklist rather than relying on memory in a stressful appointment.

Kantesti’s neural network is designed to translate laboratory language into questions you can take to a qualified clinician; our clinical validation approach explains the boundaries of that role. Most patients find that a staged plan is reassuring: not because every answer arrives at once, but because each test has a reason and a next decision attached.